These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 17521944)

  • 61. Haemapheresis activities in Germany.
    Moog R
    Transfus Apher Sci; 2005 Jun; 32(3):283-6. PubMed ID: 15944114
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Application of LDL-apheresis and immunoadsorption in kidney diseases.
    Sułowicz W; Stompór T
    Rocz Akad Med Bialymst; 2004; 49():127-34. PubMed ID: 15631328
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Establishment of a national on-line registry for apheresis in Korea.
    Song EY; Yoon JH; Lee JW; Park CW; Kwon SW; Kim DW; Lim YA; Kim HO; Han KS
    Transfus Apher Sci; 2008 Apr; 38(2):93-100. PubMed ID: 18359274
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Platelet collection during plasma exchange donation of cryoprecipitate.
    McLeod BC; Sassetti RJ; Cole ER; Scott JP
    Prog Clin Biol Res; 1990; 337():481-3. PubMed ID: 2112755
    [No Abstract]   [Full Text] [Related]  

  • 65. Volunteer donor apheresis.
    Waxman DA
    Ther Apher; 2002 Feb; 6(1):77-81. PubMed ID: 11886580
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006).
    Eder AF; Kennedy JM; Dy BA; Notari EP; Weiss JW; Fang CT; Wagner S; Dodd RY; Benjamin RJ;
    Transfusion; 2007 Jul; 47(7):1134-42. PubMed ID: 17581147
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Mode of preparation of labile blood products--available products].
    Lapierre V; Hervé P
    Presse Med; 1999 Jul 3-10; 28(24):1314-20. PubMed ID: 10442066
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Is there a need for a national or a global apheresis registry?
    Stegmayr B; Korach JM; Norda R; Rock G; Fadel F
    Transfus Apher Sci; 2003 Oct; 29(2):179-85. PubMed ID: 12941358
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 70. National French observatory of the quality of blood components for transfusion.
    Chabanel A; Masse M; Begue S;
    Transfus Clin Biol; 2008 Jun; 15(3):85-90. PubMed ID: 18524661
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of high-yield thrombocytapheresis on the quality of platelet products.
    Julmy F; Ammann RA; Mansouri Taleghani B; Fontana S; Hirt A; Leibundgut K
    Transfusion; 2008 Mar; 48(3):442-50. PubMed ID: 18067508
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The influence of simulated shipping conditions (24- or 30-hr interruption of agitation) on the in vitro properties of apheresis platelets during 7-day storage.
    Wagner SJ; Vassallo R; Skripchenko A; Einarson M; Seetharaman S; Moroff G
    Transfusion; 2008 Jun; 48(6):1072-80. PubMed ID: 18373503
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A comparative analysis of different methods for routine blood component preparation.
    Heaton WA; Rebulla P; Pappalettera M; Dzik WH
    Transfus Med Rev; 1997 Apr; 11(2):116-29. PubMed ID: 9140171
    [No Abstract]   [Full Text] [Related]  

  • 74. [Methods of platelet collection].
    Nagasawa Y
    Rinsho Byori; 1987 Jun; Spec No 71():79-84. PubMed ID: 3306050
    [No Abstract]   [Full Text] [Related]  

  • 75. Pathogen reduction of blood components.
    Solheim BG
    Transfus Apher Sci; 2008 Aug; 39(1):75-82. PubMed ID: 18602343
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The Italian Registry of Pediatric Therapeutic Apheresis: a report on activity during 2005.
    De Silvestro G; Tison T; Vicarioto M; Bagatella P; Stefanutti C; Marson P
    J Clin Apher; 2009; 24(1):1-5. PubMed ID: 19073013
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A pilot study of large volume apheresis of red blood cells and plasma during one donation by allogeneic blood donors.
    Komatsu F; Kajiwara M
    Transfus Sci; 2000 Aug; 23(1):55-61. PubMed ID: 10925054
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Apheresis donation. Current views and perspectives].
    Schooneman F
    Transfus Clin Biol; 2005 Jun; 12(2):208-11. PubMed ID: 15925528
    [No Abstract]   [Full Text] [Related]  

  • 79. What's happening: an overview of potential adverse reactions associated with apheresis technology.
    Maurício R; de Sousa G; Seghatchian J
    Transfus Apher Sci; 2005 Nov; 33(3):351-6. PubMed ID: 16226918
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Long-term LDL apheresis does not stably improve hemorheology in hypercholesterolemic patients with coronary artery disease.
    Pusl T; Broedl UC; Parhofer KG; Otto C
    Clin Hemorheol Microcirc; 2009; 41(2):137-42. PubMed ID: 19252236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.